These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 21756155

  • 1. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [Abstract] [Full Text] [Related]

  • 2. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R, Martínez-Taboada VM, Villa I, González-Vela MC, Fernández-Llaca H, Agudo M, González-López MA.
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
    Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB.
    Ann Intern Med; 2012 Dec 18; 157(12):846-55. PubMed ID: 23247938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A, Sinclair R, Foley P, Saunders H.
    Australas J Dermatol; 2010 Aug 18; 51(3):186-90. PubMed ID: 20695857
    [Abstract] [Full Text] [Related]

  • 13. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C, Buckley C.
    Br J Dermatol; 2006 Apr 18; 154(4):726-9. PubMed ID: 16536817
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
    Delage M, Samimi M, Atlan M, Machet L, Lorette G, Maruani A.
    Acta Derm Venereol; 2011 Mar 18; 91(2):169-71. PubMed ID: 21384087
    [Abstract] [Full Text] [Related]

  • 15. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP.
    Br J Dermatol; 2012 Feb 18; 166(2):298-305. PubMed ID: 22013960
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa.
    Gulliver WP, Jemec GB, Baker KA.
    J Eur Acad Dermatol Venereol; 2012 Jul 18; 26(7):911-4. PubMed ID: 21605174
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S, Rodríguez-Lojo R, Fernández-Torres R, Arévalo P, Fonseca E.
    J Dermatolog Treat; 2012 Aug 18; 23(4):278-83. PubMed ID: 22482700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.